These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 28480270)

  • 1. A Randomized Placebo Controlled Trial of Aspirin Effects on Immune Activation in Chronically Human Immunodeficiency Virus-Infected Adults on Virologically Suppressive Antiretroviral Therapy.
    O'Brien MP; Hunt PW; Kitch DW; Klingman K; Stein JH; Funderburg NT; Berger JS; Tebas P; Clagett B; Moisi D; Utay NS; Aweeka F; Aberg JA
    Open Forum Infect Dis; 2017; 4(1):ofw278. PubMed ID: 28480270
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of atorvastatin on biomarkers of immune activation, inflammation, and lipids in virologically suppressed, human immunodeficiency virus-1-infected individuals with low-density lipoprotein cholesterol <130 mg/dL (AIDS Clinical Trials Group Study A5275).
    Nixon DE; Bosch RJ; Chan ES; Funderburg NT; Hodder S; Lake JE; Lederman MM; Klingman KL; Aberg JA;
    J Clin Lipidol; 2017; 11(1):61-69. PubMed ID: 28391912
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Randomized, Double-blinded, Placebo-controlled Trial of Sitagliptin for Reducing Inflammation and Immune Activation in Treated and Suppressed Human Immunodeficiency Virus Infection.
    Dubé MP; Chan ES; Lake JE; Williams B; Kinslow J; Landay A; Coombs RW; Floris-Moore M; Ribaudo HJ; Yarasheski KE
    Clin Infect Dis; 2019 Sep; 69(7):1165-1172. PubMed ID: 30535188
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aspirin attenuates platelet activation and immune activation in HIV-1-infected subjects on antiretroviral therapy: a pilot study.
    O'Brien M; Montenont E; Hu L; Nardi MA; Valdes V; Merolla M; Gettenberg G; Cavanagh K; Aberg JA; Bhardwaj N; Berger JS
    J Acquir Immune Defic Syndr; 2013 Jul; 63(3):280-8. PubMed ID: 23406976
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rosuvastatin treatment reduces markers of monocyte activation in HIV-infected subjects on antiretroviral therapy.
    Funderburg NT; Jiang Y; Debanne SM; Storer N; Labbato D; Clagett B; Robinson J; Lederman MM; McComsey GA
    Clin Infect Dis; 2014 Feb; 58(4):588-95. PubMed ID: 24253250
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Omega-3 fatty acids do not improve endothelial function in virologically suppressed HIV-infected men: a randomized placebo-controlled trial.
    Hileman CO; Carman TL; Storer NJ; Labbato DE; White CA; McComsey GA
    AIDS Res Hum Retroviruses; 2012 Jul; 28(7):649-55. PubMed ID: 21870979
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiplatelet Effects of Clopidogrel Vs Aspirin in Virologically Controlled HIV: A Randomized Controlled Trial.
    Marcantoni E; Garshick MS; Schwartz T; Ratnapala N; Cambria M; Dann R; O'Brien M; Heguy A; Berger JS
    JACC Basic Transl Sci; 2022 Nov; 7(11):1086-1097. PubMed ID: 36687270
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of Internet Cognitive-Behavioral Therapy on Depressive Symptoms and Surrogates of Cardiovascular Risk in Human Immunodeficiency Virus: A Pilot, Randomized, Controlled Trial.
    Gupta SK; Slaven JE; Liu Z; Polanka BM; Freiberg MS; Stewart JC
    Open Forum Infect Dis; 2020 Jul; 7(7):ofaa280. PubMed ID: 32760749
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Randomized Trial of Ruxolitinib in Antiretroviral-Treated Adults With Human Immunodeficiency Virus.
    Marconi VC; Moser C; Gavegnano C; Deeks SG; Lederman MM; Overton ET; Tsibris A; Hunt PW; Kantor A; Sekaly RP; Tressler R; Flexner C; Hurwitz SJ; Moisi D; Clagett B; Hardin WR; Del Rio C; Schinazi RF; Lennox JJ
    Clin Infect Dis; 2022 Jan; 74(1):95-104. PubMed ID: 33693561
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomized controlled pilot trial of valacyclovir for attenuating inflammation and immune activation in HIV/herpes simplex virus 2-coinfected adults on suppressive antiretroviral therapy.
    Yi TJ; Walmsley S; Szadkowski L; Raboud J; Rajwans N; Shannon B; Kumar S; Kain KC; Kaul R; Tan DH
    Clin Infect Dis; 2013 Nov; 57(9):1331-8. PubMed ID: 23946220
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activated Platelets Induce Endothelial Cell Inflammatory Response in Psoriasis via COX-1.
    Garshick MS; Tawil M; Barrett TJ; Salud-Gnilo CM; Eppler M; Lee A; Scher JU; Neimann AL; Jelic S; Mehta NN; Fisher EA; Krueger JG; Berger JS
    Arterioscler Thromb Vasc Biol; 2020 May; 40(5):1340-1351. PubMed ID: 32131611
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Soluble markers of inflammation and coagulation but not T-cell activation predict non-AIDS-defining morbid events during suppressive antiretroviral treatment.
    Tenorio AR; Zheng Y; Bosch RJ; Krishnan S; Rodriguez B; Hunt PW; Plants J; Seth A; Wilson CC; Deeks SG; Lederman MM; Landay AL
    J Infect Dis; 2014 Oct; 210(8):1248-59. PubMed ID: 24795473
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extended-Release Niacin Versus Fenofibrate in HIV-Infected Participants With Low High-Density Lipoprotein Cholesterol: Effects on Endothelial Function, Lipoproteins, and Inflammation.
    Dubé MP; Komarow L; Fichtenbaum CJ; Cadden JJ; Overton ET; Hodis HN; Currier JS; Stein JH;
    Clin Infect Dis; 2015 Sep; 61(5):840-9. PubMed ID: 25979307
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HIV infection, antiretroviral therapy, and measures of endothelial function, inflammation, metabolism, and oxidative stress.
    Dysangco A; Liu Z; Stein JH; Dubé MP; Gupta SK
    PLoS One; 2017; 12(8):e0183511. PubMed ID: 28817706
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunomodulation of antiretroviral drug-suppressed chronic HIV-1 infection in an oral probiotic double-blind placebo-controlled trial.
    Yang OO; Kelesidis T; Cordova R; Khanlou H
    AIDS Res Hum Retroviruses; 2014 Oct; 30(10):988-95. PubMed ID: 25127924
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of intensified antiretroviral therapy during early HIV infection on gut immunology and inflammatory blood biomarkers.
    Kim CJ; Rousseau R; Huibner S; Kovacs C; Benko E; Shahabi K; Kandel G; Ostrowski M; Kaul R
    AIDS; 2017 Jul; 31(11):1529-1534. PubMed ID: 28463882
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of cyclooxygenase-2 inhibition with rofecoxib on endothelial dysfunction and inflammatory markers in patients with coronary artery disease.
    Title LM; Giddens K; McInerney MM; McQueen MJ; Nassar BA
    J Am Coll Cardiol; 2003 Nov; 42(10):1747-53. PubMed ID: 14642682
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of aspirin treatment on abacavir-associated platelet hyperreactivity in HIV-infected patients.
    Falcinelli E; Francisci D; Schiaroli E; Minuz P; Orsini S; Malincarne L; Sebastiano M; Mezzasoma AM; Pasticci MB; Guglielmini G; Baldelli F; Gresele P
    Int J Cardiol; 2018 Jul; 263():118-124. PubMed ID: 29685693
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Randomized, Placebo-Controlled, Pilot Clinical Trial of Dipyridamole to Decrease Human Immunodeficiency Virus-Associated Chronic Inflammation.
    Macatangay BJC; Jackson EK; Abebe KZ; Comer D; Cyktor J; Klamar-Blain C; Borowski L; Gillespie DG; Mellors JW; Rinaldo CR; Riddler SA
    J Infect Dis; 2020 Apr; 221(10):1598-1606. PubMed ID: 31282542
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lack of Atorvastatin Effect on Monocyte Gene Expression and Inflammatory Markers in HIV-1-infected ART-suppressed Individuals at Risk of non-AIDS Comorbidities.
    Yadav A; Kossenkov AV; Showe LC; Ratcliffe SJ; Choi GH; Montaner LJ; Tebas P; Shaw PA; Collman RG
    Pathog Immun; 2021; 6(2):1-26. PubMed ID: 34447895
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.